CenterBook Partners
WGS icon

CenterBook Partners’s GeneDx Holdings WGS Stock Holding History

CenterBook Partners’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-3,247
Closed -$223K – 1046
2026
Q2 		$223K Buy
+3,247
New +$185K 0.01% 672
2026
Q1 		– Sell
-17,893
Closed -$2.33M – 792
2025
Q4 		$2.33M Buy
+17,893
New +$2.46M 0.11% 243

Other funds holding WGS

William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Gagnon Securities
Gagnon Securities New York $577M AUM 61.61% 1-Year Est. Return
Zweig-DiMenna Associates
Zweig-DiMenna Associates New York $1.3B AUM 120.13% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.91% 1-Year Est. Return
GA
Gagnon Advisors New York $182M AUM 52.04% 1-Year Est. Return

CenterBook Partners's WGS Position: Q3 2026 in Review

CenterBook Partners sold out of GeneDx Holdings (WGS) in Q3 2026, closing a stake of 3,247 shares — an estimated $223K sold.

CenterBook Partners first reported a position in WGS in Q4 2025 and held it in 2 quarters. The position peaked at $2.33M in Q4 2025. 97 funds tracked by Wall St. Rank hold WGS as of Q3 2026.

  • CenterBook Partners reported no remaining GeneDx Holdings position as of Q3 2026 after selling out during the quarter.
  • CenterBook Partners sold 3,247 GeneDx Holdings shares in Q3 2026, an estimated $223K.
  • CenterBook Partners first reported a position in GeneDx Holdings in Q4 2025 and held it in 2 quarters.
  • CenterBook Partners's GeneDx Holdings position peaked at $2.33M in Q4 2025.
  • 97 funds tracked by Wall St. Rank held GeneDx Holdings as of Q3 2026.

Based on CenterBook Partners's 13F filing for Q3 2026, filed 2 Nov 2026.